img

Global Pharmaceuticals for Women's Health Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharmaceuticals for Women's Health Market Research Report 2024

This report focuses on pharmaceutical products for female-related diseases.
According to Mr Accuracy reports’s new survey, global Pharmaceuticals for Women's Health market is projected to reach US$ 41620 million in 2034, increasing from US$ 31880 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceuticals for Women's Health market research.
The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceuticals for Women's Health market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Lilly
Pfizer
Bayer
AbbVie
Amgen
Johnson&Johnson
Segment by Type
Granules
Pills
Powder
Tincture
Tablets
Capsule
Other

Segment by Application


Postmenopausal Osteoporosis
Endometriosis
Polycystic Ovarian Syndrome
Pregnancy Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pharmaceuticals for Women's Health report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceuticals for Women's Health Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Granules
1.2.3 Pills
1.2.4 Powder
1.2.5 Tincture
1.2.6 Tablets
1.2.7 Capsule
1.2.8 Other
1.3 Market by Application
1.3.1 Global Pharmaceuticals for Women's Health Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Postmenopausal Osteoporosis
1.3.3 Endometriosis
1.3.4 Polycystic Ovarian Syndrome
1.3.5 Pregnancy Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceuticals for Women's Health Market Perspective (2024-2034)
2.2 Pharmaceuticals for Women's Health Growth Trends by Region
2.2.1 Global Pharmaceuticals for Women's Health Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Pharmaceuticals for Women's Health Historic Market Size by Region (2024-2024)
2.2.3 Pharmaceuticals for Women's Health Forecasted Market Size by Region (2024-2034)
2.3 Pharmaceuticals for Women's Health Market Dynamics
2.3.1 Pharmaceuticals for Women's Health Industry Trends
2.3.2 Pharmaceuticals for Women's Health Market Drivers
2.3.3 Pharmaceuticals for Women's Health Market Challenges
2.3.4 Pharmaceuticals for Women's Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceuticals for Women's Health Players by Revenue
3.1.1 Global Top Pharmaceuticals for Women's Health Players by Revenue (2024-2024)
3.1.2 Global Pharmaceuticals for Women's Health Revenue Market Share by Players (2024-2024)
3.2 Global Pharmaceuticals for Women's Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceuticals for Women's Health Revenue
3.4 Global Pharmaceuticals for Women's Health Market Concentration Ratio
3.4.1 Global Pharmaceuticals for Women's Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceuticals for Women's Health Revenue in 2022
3.5 Pharmaceuticals for Women's Health Key Players Head office and Area Served
3.6 Key Players Pharmaceuticals for Women's Health Product Solution and Service
3.7 Date of Enter into Pharmaceuticals for Women's Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceuticals for Women's Health Breakdown Data by Type
4.1 Global Pharmaceuticals for Women's Health Historic Market Size by Type (2024-2024)
4.2 Global Pharmaceuticals for Women's Health Forecasted Market Size by Type (2024-2034)
5 Pharmaceuticals for Women's Health Breakdown Data by Application
5.1 Global Pharmaceuticals for Women's Health Historic Market Size by Application (2024-2024)
5.2 Global Pharmaceuticals for Women's Health Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Pharmaceuticals for Women's Health Market Size (2024-2034)
6.2 North America Pharmaceuticals for Women's Health Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Pharmaceuticals for Women's Health Market Size by Country (2024-2024)
6.4 North America Pharmaceuticals for Women's Health Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceuticals for Women's Health Market Size (2024-2034)
7.2 Europe Pharmaceuticals for Women's Health Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Pharmaceuticals for Women's Health Market Size by Country (2024-2024)
7.4 Europe Pharmaceuticals for Women's Health Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceuticals for Women's Health Market Size (2024-2034)
8.2 Asia-Pacific Pharmaceuticals for Women's Health Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Pharmaceuticals for Women's Health Market Size by Region (2024-2024)
8.4 Asia-Pacific Pharmaceuticals for Women's Health Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceuticals for Women's Health Market Size (2024-2034)
9.2 Latin America Pharmaceuticals for Women's Health Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Pharmaceuticals for Women's Health Market Size by Country (2024-2024)
9.4 Latin America Pharmaceuticals for Women's Health Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceuticals for Women's Health Market Size (2024-2034)
10.2 Middle East & Africa Pharmaceuticals for Women's Health Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Pharmaceuticals for Women's Health Market Size by Country (2024-2024)
10.4 Middle East & Africa Pharmaceuticals for Women's Health Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Pharmaceuticals for Women's Health Introduction
11.1.4 Allergan Revenue in Pharmaceuticals for Women's Health Business (2024-2024)
11.1.5 Allergan Recent Development
11.2 Lilly
11.2.1 Lilly Company Detail
11.2.2 Lilly Business Overview
11.2.3 Lilly Pharmaceuticals for Women's Health Introduction
11.2.4 Lilly Revenue in Pharmaceuticals for Women's Health Business (2024-2024)
11.2.5 Lilly Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pharmaceuticals for Women's Health Introduction
11.3.4 Pfizer Revenue in Pharmaceuticals for Women's Health Business (2024-2024)
11.3.5 Pfizer Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Pharmaceuticals for Women's Health Introduction
11.4.4 Bayer Revenue in Pharmaceuticals for Women's Health Business (2024-2024)
11.4.5 Bayer Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Detail
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Pharmaceuticals for Women's Health Introduction
11.5.4 AbbVie Revenue in Pharmaceuticals for Women's Health Business (2024-2024)
11.5.5 AbbVie Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Pharmaceuticals for Women's Health Introduction
11.6.4 Amgen Revenue in Pharmaceuticals for Women's Health Business (2024-2024)
11.6.5 Amgen Recent Development
11.7 Johnson&Johnson
11.7.1 Johnson&Johnson Company Detail
11.7.2 Johnson&Johnson Business Overview
11.7.3 Johnson&Johnson Pharmaceuticals for Women's Health Introduction
11.7.4 Johnson&Johnson Revenue in Pharmaceuticals for Women's Health Business (2024-2024)
11.7.5 Johnson&Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharmaceuticals for Women's Health Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Granules
Table 3. Key Players of Pills
Table 4. Key Players of Powder
Table 5. Key Players of Tincture
Table 6. Key Players of Tablets
Table 7. Key Players of Capsule
Table 8. Key Players of Other
Table 9. Global Pharmaceuticals for Women's Health Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 10. Global Pharmaceuticals for Women's Health Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 11. Global Pharmaceuticals for Women's Health Market Size by Region (2024-2024) & (US$ Million)
Table 12. Global Pharmaceuticals for Women's Health Market Share by Region (2024-2024)
Table 13. Global Pharmaceuticals for Women's Health Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 14. Global Pharmaceuticals for Women's Health Market Share by Region (2024-2034)
Table 15. Pharmaceuticals for Women's Health Market Trends
Table 16. Pharmaceuticals for Women's Health Market Drivers
Table 17. Pharmaceuticals for Women's Health Market Challenges
Table 18. Pharmaceuticals for Women's Health Market Restraints
Table 19. Global Pharmaceuticals for Women's Health Revenue by Players (2024-2024) & (US$ Million)
Table 20. Global Pharmaceuticals for Women's Health Market Share by Players (2024-2024)
Table 21. Global Top Pharmaceuticals for Women's Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals for Women's Health as of 2022)
Table 22. Ranking of Global Top Pharmaceuticals for Women's Health Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Pharmaceuticals for Women's Health Revenue (CR5 and HHI) & (2024-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Pharmaceuticals for Women's Health Product Solution and Service
Table 26. Date of Enter into Pharmaceuticals for Women's Health Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pharmaceuticals for Women's Health Market Size by Type (2024-2024) & (US$ Million)
Table 29. Global Pharmaceuticals for Women's Health Revenue Market Share by Type (2024-2024)
Table 30. Global Pharmaceuticals for Women's Health Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 31. Global Pharmaceuticals for Women's Health Revenue Market Share by Type (2024-2034)
Table 32. Global Pharmaceuticals for Women's Health Market Size by Application (2024-2024) & (US$ Million)
Table 33. Global Pharmaceuticals for Women's Health Revenue Market Share by Application (2024-2024)
Table 34. Global Pharmaceuticals for Women's Health Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 35. Global Pharmaceuticals for Women's Health Revenue Market Share by Application (2024-2034)
Table 36. North America Pharmaceuticals for Women's Health Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 37. North America Pharmaceuticals for Women's Health Market Size by Country (2024-2024) & (US$ Million)
Table 38. North America Pharmaceuticals for Women's Health Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Pharmaceuticals for Women's Health Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 40. Europe Pharmaceuticals for Women's Health Market Size by Country (2024-2024) & (US$ Million)
Table 41. Europe Pharmaceuticals for Women's Health Market Size by Country (2024-2034) & (US$ Million)
Table 42. Asia-Pacific Pharmaceuticals for Women's Health Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 43. Asia-Pacific Pharmaceuticals for Women's Health Market Size by Region (2024-2024) & (US$ Million)
Table 44. Asia-Pacific Pharmaceuticals for Women's Health Market Size by Region (2024-2034) & (US$ Million)
Table 45. Latin America Pharmaceuticals for Women's Health Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 46. Latin America Pharmaceuticals for Women's Health Market Size by Country (2024-2024) & (US$ Million)
Table 47. Latin America Pharmaceuticals for Women's Health Market Size by Country (2024-2034) & (US$ Million)
Table 48. Middle East & Africa Pharmaceuticals for Women's Health Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 49. Middle East & Africa Pharmaceuticals for Women's Health Market Size by Country (2024-2024) & (US$ Million)
Table 50. Middle East & Africa Pharmaceuticals for Women's Health Market Size by Country (2024-2034) & (US$ Million)
Table 51. Allergan Company Detail
Table 52. Allergan Business Overview
Table 53. Allergan Pharmaceuticals for Women's Health Product
Table 54. Allergan Revenue in Pharmaceuticals for Women's Health Business (2024-2024) & (US$ Million)
Table 55. Allergan Recent Development
Table 56. Lilly Company Detail
Table 57. Lilly Business Overview
Table 58. Lilly Pharmaceuticals for Women's Health Product
Table 59. Lilly Revenue in Pharmaceuticals for Women's Health Business (2024-2024) & (US$ Million)
Table 60. Lilly Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Pharmaceuticals for Women's Health Product
Table 64. Pfizer Revenue in Pharmaceuticals for Women's Health Business (2024-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Bayer Company Detail
Table 67. Bayer Business Overview
Table 68. Bayer Pharmaceuticals for Women's Health Product
Table 69. Bayer Revenue in Pharmaceuticals for Women's Health Business (2024-2024) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. AbbVie Company Detail
Table 72. AbbVie Business Overview
Table 73. AbbVie Pharmaceuticals for Women's Health Product
Table 74. AbbVie Revenue in Pharmaceuticals for Women's Health Business (2024-2024) & (US$ Million)
Table 75. AbbVie Recent Development
Table 76. Amgen Company Detail
Table 77. Amgen Business Overview
Table 78. Amgen Pharmaceuticals for Women's Health Product
Table 79. Amgen Revenue in Pharmaceuticals for Women's Health Business (2024-2024) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. Johnson&Johnson Company Detail
Table 82. Johnson&Johnson Business Overview
Table 83. Johnson&Johnson Pharmaceuticals for Women's Health Product
Table 84. Johnson&Johnson Revenue in Pharmaceuticals for Women's Health Business (2024-2024) & (US$ Million)
Table 85. Johnson&Johnson Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceuticals for Women's Health Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Pharmaceuticals for Women's Health Market Share by Type: 2022 VS 2034
Figure 3. Granules Features
Figure 4. Pills Features
Figure 5. Powder Features
Figure 6. Tincture Features
Figure 7. Tablets Features
Figure 8. Capsule Features
Figure 9. Other Features
Figure 10. Global Pharmaceuticals for Women's Health Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Pharmaceuticals for Women's Health Market Share by Application: 2022 VS 2034
Figure 12. Postmenopausal Osteoporosis Case Studies
Figure 13. Endometriosis Case Studies
Figure 14. Polycystic Ovarian Syndrome Case Studies
Figure 15. Pregnancy Disorders Case Studies
Figure 16. Others Case Studies
Figure 17. Pharmaceuticals for Women's Health Report Years Considered
Figure 18. Global Pharmaceuticals for Women's Health Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 19. Global Pharmaceuticals for Women's Health Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 20. Global Pharmaceuticals for Women's Health Market Share by Region: 2022 VS 2034
Figure 21. Global Pharmaceuticals for Women's Health Market Share by Players in 2022
Figure 22. Global Top Pharmaceuticals for Women's Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals for Women's Health as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Pharmaceuticals for Women's Health Revenue in 2022
Figure 24. North America Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. North America Pharmaceuticals for Women's Health Market Share by Country (2024-2034)
Figure 26. United States Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Canada Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Europe Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Europe Pharmaceuticals for Women's Health Market Share by Country (2024-2034)
Figure 30. Germany Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. France Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. U.K. Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Italy Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Russia Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Nordic Countries Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Asia-Pacific Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Asia-Pacific Pharmaceuticals for Women's Health Market Share by Region (2024-2034)
Figure 38. China Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Japan Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. South Korea Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Southeast Asia Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. India Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Australia Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Latin America Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Latin America Pharmaceuticals for Women's Health Market Share by Country (2024-2034)
Figure 46. Mexico Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Brazil Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 48. Middle East & Africa Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Pharmaceuticals for Women's Health Market Share by Country (2024-2034)
Figure 50. Turkey Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 51. Saudi Arabia Pharmaceuticals for Women's Health Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 52. Allergan Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2024-2024)
Figure 53. Lilly Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2024-2024)
Figure 54. Pfizer Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2024-2024)
Figure 55. Bayer Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2024-2024)
Figure 56. AbbVie Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2024-2024)
Figure 57. Amgen Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2024-2024)
Figure 58. Johnson&Johnson Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2024-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed